Description

4-(1H-Imidazol-1-Ylmethyl)-n-Methylbenzylamine Sesquioxalate Hemihydrate is a high-purity, complex organic salt used as a key intermediate in advanced pharmaceutical synthesis. This compound matters for its role in the development of targeted therapeutic agents, particularly in areas requiring specific molecular scaffolds. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the discovery and production of novel active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly those targeting specific enzyme pathways.
• Biochemical Research: Used as a reference standard or reagent in proteomics and enzyme inhibition studies.
• Chemical Synthesis: Serves as a versatile precursor for the development of more complex molecules with imidazole and benzylamine functionalities.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to optimize the potency and selectivity of lead compounds.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.
• Academic Research: Utilized in university and institutional labs for exploratory research in organic and medicinal chemistry.

Basic Information

Product Name	4-(1H-Imidazol-1-Ylmethyl)-n-Methylbenzylamine Sesquioxalate Hemihydrate
CAS No.	910036-84-9
Molecular Formula	C13H15N3 · 1.5C2H2O4 · 0.5H2O
Molecular Weight	Contact for details
Synonyms	4-[(1H-Imidazol-1-yl)methyl]-N-methylbenzenemethanamine sesquioxalate hemihydrate; 1-[(4-{[(Methylamino)methyl]phenyl}methyl]-1H-imidazole sesquioxalate hemihydrate; N-Methyl-4-(imidazol-1-ylmethyl)benzylamine sesquioxalate hemihydrate; 4-(Imidazol-1-ylmethyl)-N-methylbenzylamine oxalate (1:1.5) hydrate (2:3); 910036-84-9; 4-(1H-Imidazol-1-ylmethyl)-N-methylbenzylamine oxalic acid salt; 4-(Imidazol-1-ylmethyl)-N-methylbenzylamine hemioxalate hemihydrate
EINECS	Contact for details

Quality Control

Our 4-(1H-Imidazol-1-Ylmethyl)-n-Methylbenzylamine Sesquioxalate Hemihydrate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical research and development. Certificates of Analysis (COA) detailing batch-specific results are available upon request, supporting compliance with relevant research and cGMP guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. Long-term storage under inert atmosphere is recommended.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	2.0% - 5.0% (Theoretical for hemihydrate)
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.